Akums Drugs and Pharmaceuticals inches up on entering into MoU with Government of Republic of Zambia
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Akums Drugs & Pharmaceuticals is currently trading at Rs. 915.00, up by 0.25 points or 0.03% from its previous closing of Rs. 914.75 on the BSE.
The scrip opened at Rs. 896.00 and has touched a high and low of Rs. 935.00 and Rs. 896.00 respectively. So far 17573 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 1174.85 on 20-Aug-2024 and a 52 week low of Rs. 724.50 on 06-Aug-2024.
Last one week high and low of the scrip stood at Rs. 935.00 and Rs. 815.00 respectively. The current market cap of the company is Rs. 14355.12 crore.
The promoters holding in the company stood at 75.26%, while Institutions and Non-Institutions held 14.58% and 10.16% respectively.
Akums Drugs and Pharmaceuticals (Akums) has entered into a Memorandum of Understanding (MoU) with The Government of Republic of Zambia through Ministry of Health situated at Ndeke House, Haile Selassie Road Lusaka in Lusaka Province for Local Manufacturing of Medicines and to recognize the existing collaboration between the Zambian Government and Akums in the field of medicines and medical supplies and to strengthen collaboration between the entities.
Akums Drugs & Pharmaceuticals is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.
.jpg)
